Page last updated: 2024-10-21

3-aminobenzamide and Heart Arrest

3-aminobenzamide has been researched along with Heart Arrest in 2 studies

Heart Arrest: Cessation of heart beat or MYOCARDIAL CONTRACTION. If it is treated within a few minutes, heart arrest can be reversed in most cases to normal cardiac rhythm and effective circulation.

Research Excerpts

ExcerptRelevanceReference
"After 60 min of hypothermic cardiac arrest, reperfusion was started after application of either saline vehicle (control, n = 6), or INO-1001 (1 mg/kg), a potent PARP inhibitor (n = 6)."1.32INO-1001 a novel poly(ADP-ribose) polymerase (PARP) inhibitor improves cardiac and pulmonary function after crystalloid cardioplegia and extracorporal circulation. ( Bährle, S; Cziráki, A; Flechtenmacher, C; Gries, A; Hagl, S; Heger, U; Mandera, S; Seres, L; Soós, P; Szabó, C; Szabó, G; Vahl, CF; Zsengellér, Z, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yeh, CH1
Chen, TP1
Lee, CH1
Wu, YC1
Lin, YM1
Jing Lin, P1
Szabó, G1
Soós, P1
Mandera, S1
Heger, U1
Flechtenmacher, C1
Bährle, S1
Seres, L1
Cziráki, A1
Gries, A1
Zsengellér, Z1
Vahl, CF1
Hagl, S1
Szabó, C1

Other Studies

2 other studies available for 3-aminobenzamide and Heart Arrest

ArticleYear
Inhibition of poly(adp-ribose) polymerase reduces cardiomyocytic apoptosis after global cardiac arrest under cardiopulmonary bypass.
    Shock (Augusta, Ga.), 2006, Volume: 25, Issue:2

    Topics: Aminobenzoates; Animals; Apoptosis; Benzamides; Cardioplegic Solutions; Cardiopulmonary Bypass; Enzy

2006
INO-1001 a novel poly(ADP-ribose) polymerase (PARP) inhibitor improves cardiac and pulmonary function after crystalloid cardioplegia and extracorporal circulation.
    Shock (Augusta, Ga.), 2004, Volume: 21, Issue:5

    Topics: Acetylcholine; Adenosine Diphosphate Ribose; Animals; Disease Models, Animal; Dogs; Enzyme Inhibitor

2004